Human Gene AXIN1 (ENST00000262320.8_8) from GENCODE V47lift37
|
|
Sequence and Links to Tools and Databases
|
|
Comments and Description Text from UniProtKB
|
|
ID: AXIN1_HUMAN
DESCRIPTION: RecName: Full=Axin-1; AltName: Full=Axis inhibition protein 1; Short=hAxin;
FUNCTION: Component of the beta-catenin destruction complex required for regulating CTNNB1 levels through phosphorylation and ubiquitination, and modulating Wnt-signaling. Controls dorsoventral patterning via two opposing effects; down-regulates CTNNB1 to inhibit the Wnt signaling pathway and ventralize embryos, but also dorsalizes embryos by activating a Wnt- independent JNK signaling pathway. In Wnt signaling, probably facilitates the phosphorylation of CTNNB1 and APC by GSK3B. Likely to function as a tumor suppressor. Facilitates the phosphorylation of TP53 by HIPK2 upon ultraviolet irradiation. Enhances TGF-beta signaling by recruiting the RNF111 E3 ubiquitin ligase and promoting the degradation of inhibitory SMAD7. Also component of the AXIN1-HIPK2-TP53 complex which controls cell growth, apoptosis and development. SUBUNIT: Homodimer (By similarity). Component of the beta-catenin destruction complex, containing at least, CTNNB1, an axin and GSK3B, that regulates CTNNB1 protein levels through phosphorylation and ubiquitination. Interacts with CTNNB1 (via the armadillo repeats 2-7). Interacts with GSK3B; the interaction hyperphosphorylates CTNNB1 leading to its ubiquitination and destruction. Component of the AXIN1-HIPK2-TP53 complex. Interacts directly in the complex with TP53 and HIPK2. Interacts with DAXX; the interaction stimulates the interaction of DAXX with TP53, stimulates 'Ser-46' phosphorylation of TP53 and induces cell death on UV irradiation. Also binds APC, SMAD6, SMAD7 and RNF111. Interacts with DIXDC1; prevents interaction with MAP3K1. Interacts with MAP3K4. Interacts with ANKRD6 and AIDA (By similarity). Interacts with MDFI; the interaction decreases AXIN1-mediated JUN N-terminal kinase (JNK) activation. Interacts with MDFIC; the interaction inhibits beta-cateninin-mediated signaling and AXIN1- mediated JUN N-terminal kinase (JNK) activation. Interacts with LRP5 (via its phosphorylated PPPSP motifs); the interaction is stimulated by WNT1 and GSK3B and activates beta-catenin signaling. Interacts (via the C-terminal) with PPP1CA; the interaction dephosphorylates AXIN1 and regulates interaction with GSK3B. Interacts with PPP2CA; the interaction dephosphorylates AXIN1. Interacts with MACF1 (By similarity). Found in a complex composed of MACF1, APC, AXIN1, CTNNB1 and GSK3B (By similarity). Interacts with TNKS. Interacts with DAB2; the interaction is mutually exclusive with the AXIN1:PPP1CA interaction. INTERACTION: P39687:ANP32A; NbExp=2; IntAct=EBI-710484, EBI-359234; Q14194:CRMP1; NbExp=2; IntAct=EBI-710484, EBI-473101; P49674:CSNK1E; NbExp=4; IntAct=EBI-710484, EBI-749343; P35222:CTNNB1; NbExp=20; IntAct=EBI-710484, EBI-491549; Q02248:Ctnnb1 (xeno); NbExp=5; IntAct=EBI-710484, EBI-397872; Q9UKB1:FBXW11; NbExp=4; IntAct=EBI-710484, EBI-355189; P49841:GSK3B; NbExp=26; IntAct=EBI-710484, EBI-373586; Q9H2K2:TNKS2; NbExp=2; IntAct=EBI-710484, EBI-4398527; P04637:TP53; NbExp=4; IntAct=EBI-710484, EBI-366083; Q14134:TRIM29; NbExp=2; IntAct=EBI-710484, EBI-702370; SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Cell membrane (By similarity). Note=MACF1 is required for its translocation to cell membrane (By similarity). On UV irradiation, translocates to the nucleus and colocalizes with DAAX. TISSUE SPECIFICITY: Ubiquitously expressed. DOMAIN: The tankyrase-binding motif (also named TBD) is required for interaction with tankyrase TNKS and TNKS2. PTM: Phosphorylation and dephosphorylation of AXIN1 regulates assembly and function of the beta-catenin complex. Phosphorylated by CK1 and GSK3B. Dephosphorylated by PPP1CA and PPP2CA. Phosphorylation by CK1 enhances binding of GSK3B to AXIN1. PTM: ADP-ribosylated by tankyrase TNKS and TNKS2. Poly-ADP- ribosylated protein is recognized by RNF146, followed by ubiquitination at 'Lys-48' and subsequent activation of the Wnt signaling pathway. PTM: Ubiquitinated by RNF146 when poly-ADP-ribosylated, leading to its degradation and subsequent activation of the Wnt signaling pathway. Sumoylation at Lys-857 and Lys-860 prevents ubiquitination and degradation. Sumoylation is required for AXIN1- mediated JNK activation. Deubiquitinated by USP34, deubiquitinated downstream of beta-catenin stabilization step: deubiquitination is important for nuclear accumulation during Wnt signaling to positively regulate beta-catenin (CTNBB1)-mediated transcription. DISEASE: Defects in AXIN1 are involved in hepatocellular carcinoma (HCC) [MIM:114550]. DISEASE: Defects in AXIN1 are a cause of caudal duplication anomaly (CADUA) [MIM:607864]. Caudal duplication anomaly is characterized by the occurrence of duplications of different organs in the caudal region. Note=Caudal duplication anomaly is associated with hypermethylation of the AXIN1 promoter. SIMILARITY: Contains 1 DIX domain. SIMILARITY: Contains 1 RGS domain. SEQUENCE CAUTION: Sequence=AAC51624.1; Type=Erroneous initiation; Note=Translation N-terminally shortened;
| |
|
|
Primer design for this transcript
|
|
MalaCards Disease Associations
|
|
Comparative Toxicogenomics Database (CTD)
|
|
The following chemicals interact with this gene
- C006780
bisphenol A
- D011374
Progesterone
- C111118
2',3,3',4',5-pentachloro-4-hydroxybiphenyl
- C404910
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane
- C016403
2,4-dinitrotoluene
- C053876
6-isopropoxy-9-oxoxanthene-2-carboxylic acid
- D015123
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide
- C046926
AH 23848
- D000082
Acetaminophen
- D000643
Ammonium Chloride
more ... click here to view the complete list
| |
|
|
Common Gene Haplotype Alleles
|
|
Press "+" in the title bar above to open this section.
| |
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
mRNA Secondary Structure of 3' and 5' UTRs
|
|
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
| |
|
|
Protein Domain and Structure Information
|
|
InterPro Domains: Graphical view of domain structure IPR014936 - Axin_b-cat-bd
IPR001158 - DIX
IPR000342 - Regulat_G_prot_signal
IPR024066 - Regulat_G_prot_signal_dom1
IPR016137 - Regulat_G_prot_signal_superfam
Pfam Domains: PF00615 - Regulator of G protein signaling domain
PF00778 - DIX domain
PF08833 - Axin beta-catenin binding motif
PF16646 - Axin-1 tankyrase binding domain
SCOP Domains: 48097 - Regulator of G-protein signaling, RGS
54236 - Ubiquitin-like
Protein Data Bank (PDB) 3-D Structure
ModBase Predicted Comparative 3D Structure on O15169
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
| |
|
|
Gene Ontology (GO) Annotations with Structured Vocabulary
|
|
Descriptions from all associated GenBank mRNAs
|
|
AB208876 - Homo sapiens mRNA for axin 1 isoform a variant protein. BC035872 - Homo sapiens, clone IMAGE:5309734, mRNA. KF615850 - Homo sapiens clone WBr-AK2013F1 axin-1 variant-like (AXIN1) mRNA, complete sequence, alternatively spliced. KF615851 - Homo sapiens clone WBr-AK2013F2 axin-1 variant-like (AXIN1) mRNA, complete sequence, alternatively spliced. KF615852 - Homo sapiens clone WBr-AK2013F3 axin-1 variant-like (AXIN1) mRNA, complete sequence, alternatively spliced. KF615847 - Homo sapiens clone WBr-AK2013A1 axin-1 variant-like (AXIN1) mRNA, complete sequence, alternatively spliced. KF615848 - Homo sapiens clone WBr-AK2013A2 axin-1 variant-like (AXIN1) mRNA, complete sequence, alternatively spliced. KF615849 - Homo sapiens clone WBr-AK2013A3 axin-1 variant-like (AXIN1) mRNA, complete sequence, alternatively spliced. KF615853 - Homo sapiens clone WBr-AK2013A4 axin-1 variant-like (AXIN1) mRNA, complete sequence, alternatively spliced. KF615854 - Homo sapiens clone WBr-AK2013A5 axin-1 variant-like (AXIN1) mRNA, complete sequence, alternatively spliced. AF009674 - Homo sapiens axin (AXIN) mRNA, partial cds. BC044648 - Homo sapiens axin 1, mRNA (cDNA clone MGC:52315 IMAGE:5809104), complete cds. KU178413 - Homo sapiens axin 1 isoform 1 (AXIN1) mRNA, partial cds. KU178414 - Homo sapiens axin 1 isoform 2 (AXIN1) mRNA, partial cds. KU178415 - Homo sapiens axin 1 isoform 3 (AXIN1) mRNA, partial cds, alternatively spliced. BC017447 - Homo sapiens, clone IMAGE:3506533, mRNA, partial cds. BX648449 - Homo sapiens mRNA; cDNA DKFZp686J15273 (from clone DKFZp686J15273). JD383178 - Sequence 364202 from Patent EP1572962. JD162324 - Sequence 143348 from Patent EP1572962. JD155714 - Sequence 136738 from Patent EP1572962. JD367549 - Sequence 348573 from Patent EP1572962. JD452077 - Sequence 433101 from Patent EP1572962. JD050543 - Sequence 31567 from Patent EP1572962. JD201897 - Sequence 182921 from Patent EP1572962. JD537556 - Sequence 518580 from Patent EP1572962. JD258602 - Sequence 239626 from Patent EP1572962. JD058422 - Sequence 39446 from Patent EP1572962. JD547469 - Sequence 528493 from Patent EP1572962. JD255116 - Sequence 236140 from Patent EP1572962. JD209478 - Sequence 190502 from Patent EP1572962. JD532879 - Sequence 513903 from Patent EP1572962. JD126983 - Sequence 108007 from Patent EP1572962. JD473778 - Sequence 454802 from Patent EP1572962. JD178742 - Sequence 159766 from Patent EP1572962. JD384632 - Sequence 365656 from Patent EP1572962. JD143122 - Sequence 124146 from Patent EP1572962. JD451409 - Sequence 432433 from Patent EP1572962. JD099873 - Sequence 80897 from Patent EP1572962. JD389969 - Sequence 370993 from Patent EP1572962. JD129242 - Sequence 110266 from Patent EP1572962.
| |
|
|
Biochemical and Signaling Pathways
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: AXIN, AXIN1_HUMAN, ENST00000262320.1, ENST00000262320.2, ENST00000262320.3, ENST00000262320.4, ENST00000262320.5, ENST00000262320.6, ENST00000262320.7, NM_003502, O15169, Q4TT26, Q4TT27, Q86YA7, Q8WVW6, Q96S28, uc317gzc.1, uc317gzc.2 UCSC ID: ENST00000262320.8_8 RefSeq Accession: NM_003502.4
Protein: O15169
(aka AXIN1_HUMAN)
| |
|
|
Gene Model Information
|
|
Click here
for a detailed description of the fields of the table above.
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|